Efficacy thresholds and target populations for antiviral COVID-19 treatments to save lives and costs: a modelling studyResearch in context

Summary: Background: In 2023 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared endemic, yet hospital admissions have persisted and risen within populations at high and moderate risk of developing severe disease, which include those of older age, and those with co-morbidities...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Epke A. Le Rutte, Andrew J. Shattock, Inês Marcelino, Sophie Goldenberg, Melissa A. Penny
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2024-07-01
سلاسل:	EClinicalMedicine
الموضوعات:	SARS-CoV-2 Treatment Transmission modelling Economic and public health impact
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2589537024002621
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!